MedTech Spectrum

Article Name Europe

Dawn Health and Merck Launch Advanced Digital Platform for Growth Disorder Management

Next-generation ecosystem enhances treatment adherence, remote monitoring, and personalized support for patients with growth hormone disorders.

07th May, 2025

Implantica Expands RefluxStop™ Access with New Center of Excellence in Spain

Hospital Universitario Central de Asturias joins European network to offer innovative acid reflux implant as Implantica scales treatment reach across the region.

06th May, 2025

Aptamer Group and Neuro-Bio Adapt Saliva-Based Alzheimer’s Test to ELISA Format, Advancing Towards Commercialisation

The partnership aims to deliver a non-invasive, hospital-compatible diagnostic using Aptamer’s Optimer binders and Neuro-Bio’s novel early-stage biomarker, with commercial rollout targeted within 12–18 months.

06th May, 2025

Siemens Healthineers Introduces Europe-Focused 1.5T MRI System Optimized for Radiation Therapy Without Quench Pipe Constraints

Magnetom Flow RT Pro Edition enables adaptive radiotherapy with AI-powered imaging, helium-independent cooling, and simplified installation near linear accelerators for enhanced patient care.

06th May, 2025

Royal Marsden First to Use RaySearch Adaptive Radiotherapy in Cancer Care

UK hospital becomes first globally to treat patient with new module for online adaptive radiotherapy

05th May, 2025

IBA Launches GRID3D Advantage for MR Image Distortion Analysis

New QA system aims to enhance geometric accuracy in MR-guided radiation therapy and stereotactic planning

05th May, 2025

RaySearch and Vision RT Integrate Surface Guidance into RayStation for Safer Radiotherapy Planning

ESTRO debut highlights breakthrough in collision-free, non-coplanar beam planning through surface-guided technology integration

05th May, 2025

GammaPod Introduces Single-Session High-Dose Stereotactic Radiotherapy for Breast Cancer in Europe

A new technology marks a turning point in the treatment of early-stage breast cancer

30th April, 2025

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent

29th April, 2025

Europe: Sanoculis Earns CE Mark for MINT® Device in Glaucoma Treatment

The minimally invasive MINT® procedure offers a novel, sutureless solution for managing intraocular pressure in glaucoma patients.

18th April, 2025

Eko Health Launches AI Stethoscope Platform in the UK

Clinicians across the United Kingdom can now access Eko's advanced digital stethoscopes, auscultation accessories, and AI-supported tools via EkoHealth.com and Amazon UK.

16th April, 2025

Turbett Surgical Secures FDA 510(k) Clearance for Enhanced Instrument Pod Portfolio

New TS1200 model supports up to 300 lbs, offering hospitals a more efficient, scalable solution for surgical instrument transport and storage.

14th April, 2025

Inbiome Shatters Diagnostic Delays: IVDR-Certified Platform IDs Bacteria in 5 Hours Across EU Hospitals

Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID for Critical Cases. Molecular Fingerprinting: AI-Powered ‘DNA Barcode’ Spots 200+ Species, Including Uncultivable Pathogens. Hospital Laboratories Across Europe Now Have Immediate Access To a Fully Certified, Untargeted Molecular Diagnostics Platform.

11th April, 2025

ZEISS Receives FDA Clearance for INTRABEAM 700 – Germany

Robotic-Assisted Platform Enhances Intraoperative Radiation Therapy for Neuro-Oncology and Breast Cancer Treatments

10th April, 2025

Orexo Reports Positive Data for Powder-Based Intranasal Vaccine with AmorphOX® Technology – Sweden

The collaboration is in line with Orexo's strategy to broaden the use of its powder-based drug delivery technology, AmorphOX®.

10th April, 2025

Sectra Expands Fully Managed AI Offering to Pathology with New Paige.AI Partnership – Sweden

Collaboration Enhances Cancer Diagnostics by Integrating Advanced AI into Unified Imaging Workflows

09th April, 2025

Osteopore secures European approval for custom orthopaedic and cranial implants

• Osteopore secures European Union Medical Device Regulation (EU MDR) approval to supply its cutting-edge custom orthopaedic and cranial implants. • EU MDR approval unlocks opportunities to offer high-value, custom implants to Europe, in addition to off-the-shelf implants, introducing new revenue streams. • Regulatory clearance validates Osteopore’s orthopaedic and cranial products in Europe, strengthening the Company’s positioning in the market. • The European orthopaedic market is projected to grow at a CAGR of 3.3% (2029),while the cranial implant market is expected to grow at a CAGR of 9.4% (2030).

09th April, 2025